Data / Drug companies / Piramal Pharma Limited
Piramal Pharma Limited: 42 products in the FDA NDC directory, labeler code 65085
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Piramal Pharma Limited (labeler code 65085) lists 42 products in the FDA National Drug Code Directory. By type: 35 bulk ingredients, 7 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on July 15, 2025.
The request: Watch Piramal Pharma Limited (FDA labeler code 65085): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 65085
- Products in commercial distribution
- 42
- Packages
- 261
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 4
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- March 8, 1999
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 35 | 83.3% |
| Drugs for further processing | 7 | 16.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 35 | 83.3% |
| Drugs for further processing | 7 | 16.7% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 41 | 97.6% |
| Liquid | 1 | 2.4% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Levoketoconazole | 65085-0078 | Powder | Drugs for further processing | July 15, 2025 |
| Dexlansoprazole | 65085-0070 | Powder | Bulk ingredients | March 1, 2025 |
| Vibegron | 65085-0079 | Powder | Drugs for further processing | February 15, 2024 |
| Eluxadoline | 65085-0080 | Powder | Drugs for further processing | January 5, 2024 |
| Droxidopa | 65085-0071 | Powder | Drugs for further processing | January 2, 2023 |
| Dapagliflozin propanediol monohydrate | 65085-0068 | Powder | Drugs for further processing | January 2, 2023 |
| Mecamylamine hydrochloride | 65085-0075 | Powder | Bulk ingredients | August 3, 2022 |
| Armodafinil | 65085-0058 | Powder | Bulk ingredients | July 26, 2022 |
| Rimegepant sulphate | 65085-0081 | Powder | Bulk ingredients | October 1, 2021 |
| Paliperidone palmitate | 65085-0066 | Powder | Bulk ingredients | August 3, 2021 |
| Azilsartan kamedoxomil | 65085-0074 | Powder | Bulk ingredients | March 31, 2021 |
| Varenicline tartrate | 65085-0073 | Powder | Bulk ingredients | February 15, 2021 |
| Succimer | 65085-0072 | Powder | Bulk ingredients | November 10, 2020 |
| Tolcapone | 65085-0032 | Powder | Bulk ingredients | December 31, 2018 |
| Amiodarone hydrochloride | 65085-0022 | Powder | Bulk ingredients | December 31, 2018 |
| Tetrabenazine | 65085-0064 | Powder | Bulk ingredients | December 28, 2018 |
| Deferasirox | 65085-0063 | Powder | Bulk ingredients | December 28, 2018 |
| Oxybutynin chloride | 65085-0013 | Powder | Bulk ingredients | December 27, 2018 |
| Clobazam | 65085-0054 | Powder | Bulk ingredients | December 21, 2018 |
| Cinacalcet hydrochloride | 65085-0052 | Powder | Bulk ingredients | November 21, 2018 |
| Aprepitant | 65085-0043 | Powder | Bulk ingredients | November 21, 2018 |
| Brimonidine tartrate | 65085-0030 | Powder | Bulk ingredients | November 21, 2018 |
| Lurasidone hydrochloride | 65085-0053 | Powder | Bulk ingredients | November 19, 2018 |
| Mirabegron | 65085-0067 | Powder | Bulk ingredients | November 16, 2018 |
| Bexagliflozin | 65085-0065 | Powder | Bulk ingredients | September 26, 2018 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.